We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+0.02%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$182B
AUM Growth
-$8.9B
Cap. Flow
-$1.05B
Cap. Flow %
-0.58%
Top 10 Hldgs %
39.59%
Holding
518
New
26
Increased
181
Reduced
122
Closed
19

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$3.07B
2
YMM icon
Full Truck Alliance
YMM
+$1.57B
3
RMD icon
ResMed
RMD
+$715M
4
NVDA icon
NVIDIA
NVDA
+$647M
5
BABA icon
Alibaba
BABA
+$597M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 26.6%
2 Healthcare 23.23%
3 Technology 20.07%
4 Communication Services 12.81%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLUE
451
DELISTED
bluebird bio
BLUE
$9K ﹤0.01%
43
-23
-35% -$5.43K
COLM icon
452
Columbia Sportswear
COLM
$2.94B
$9K ﹤0.01%
95
HI
453
DELISTED
Hillenbrand
HI
$9K ﹤0.01%
170
PRCT icon
454
Procept Biorobotics
PRCT
$1.17B
$9K ﹤0.01%
+376
New +$13.9K
TU icon
455
Telus
TU
$15.3B
$9K ﹤0.01%
397
WLY icon
456
John Wiley & Sons Class A
WLY
$2.66B
$9K ﹤0.01%
153
YELP icon
457
Yelp
YELP
$1.41B
$9K ﹤0.01%
262
CERS icon
458
Cerus
CERS
$474M
$8K ﹤0.01%
1,143
MATV icon
459
Mativ Holdings
MATV
$711M
$8K ﹤0.01%
265
SDGR icon
460
Schrodinger
SDGR
$1.36B
$8K ﹤0.01%
242
VUZI icon
461
Vuzix
VUZI
$224M
$8K ﹤0.01%
924
ONEM
462
DELISTED
1Life Healthcare
ONEM
$8K ﹤0.01%
445
BMRN icon
463
BioMarin Pharmaceuticals
BMRN
$12.4B
$7K ﹤0.01%
82
KYNB
464
Kyntra Bio
KYNB
$29.4M
$7K ﹤0.01%
19
FSLY icon
465
Fastly Inc
FSLY
$3.66B
$7K ﹤0.01%
205
FVRR icon
466
Fiverr
FVRR
$339M
$7K ﹤0.01%
61
OXM icon
467
Oxford Industries
OXM
$552M
$7K ﹤0.01%
73
TSVT
468
DELISTED
2seventy bio
TSVT
$7K ﹤0.01%
+286
New +$8.92K
POLY
469
DELISTED
Plantronics, Inc.
POLY
$7K ﹤0.01%
254
AGIO icon
470
Agios Pharmaceuticals
AGIO
$1.93B
$6K ﹤0.01%
186
CGNT icon
471
Cognyte Software
CGNT
$680M
$6K ﹤0.01%
369
FOLD
472
DELISTED
Amicus Therapeutics
FOLD
$6K ﹤0.01%
538
MASS icon
473
908 Devices
MASS
$364M
$6K ﹤0.01%
249
NNDM
474
Nano Dimension
NNDM
$343M
$6K ﹤0.01%
1,600
ZD icon
475
Ziff Davis
ZD
$1.98B
$6K ﹤0.01%
53
-31
-37% -$3.67K

Similar funds

Baillie Gifford & Co's Q4 2021 Portfolio in Review

As of Q4 2021, Baillie Gifford & Co held 518 positions worth $182B, down 4.7% from $191B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Baillie Gifford & Co's Q4 2021 filing shows 26 new, 181 increased, 122 reduced and 19 closed positions. Its largest new stake was Charles Schwab: 7,506,268 shares worth $631M. The largest sale was Tesla, an estimated $3.07B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Technology.

  • Baillie Gifford & Co's largest Q4 2021 buy was Charles Schwab: 7,506,268 shares worth $631M.
  • Baillie Gifford & Co added most to Moderna in Q4 2021, an estimated $1.04B increase.
  • Baillie Gifford & Co's biggest Q4 2021 reduction was Tesla, cutting an estimated $3.07B.
  • Baillie Gifford & Co fully exited Autohome in Q4 2021, selling an estimated $140M.
  • Baillie Gifford & Co's ten largest holdings make up 40% of its $182B portfolio in Q4 2021.
  • Baillie Gifford & Co opened 26 new positions and closed 19 in Q4 2021.
  • Baillie Gifford & Co's portfolio value fell 4.7% quarter-over-quarter to $182B.

Based on Baillie Gifford & Co's 13F filing for Q4 2021, filed 20 Jan 2022.